Alik Farber, MD
Boston University Chobanian & Avedisian School of Medicine
Vascular and Endovascular Surgery

MD, Harvard Medical School
BS, Brown University

Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.

Section Chief
Boston University Chobanian & Avedisian School of Medicine
Vascular and Endovascular Surgery

Boston University Chobanian & Avedisian School of Medicine
Vascular & Interventional

Boston University
Evans Center for Interdisciplinary Biomedical Research

A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols
05/01/2012 - 12/31/2015 (PI)
Grifols Inc.

A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm^2 to <= 36 cm^2
10/15/2013 - 08/30/2015 (PI)
HealthPoint Limited

A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer
05/01/2012 - 04/30/2015 (PI)
HealthPoint Limited

Observational Study of Tissue Plasminogen Activator Used for Catheter Directed Thrombolysis in Patients with Acute Lower Extremety Native Artery or Bypass Graft Occlusion
01/27/2014 - 01/26/2015 (PI)
Grifols Inc.

A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
05/01/2012 - 04/30/2014 (PI)
HealthPoint Limited

Vital Access Venous Window Needle Guide for salvage of AV Fistulae (SAVE) Trial
08/15/2012 - 08/14/2013 (PI)
Vital Access Corp

IN-BALANCE VLU (Inflammation, Bacteria, and Angiogenesis effects in launching venous leg ulcer healing: a clinical evaluation)
08/01/2012 - 07/31/2013 (PI)
Celleration, Inc.

A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals

A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals

A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
08/01/2009 - 12/31/2011 (PI)
HealthPoint Limited

Showing 10 of 16 results. Show All Results

12/09/2022 - 12/09/2025 (PI)
LimFlow Inc

Assessment of Wound Closure Comparing Synthetic Hybrid- Scale Fiber Matrix with Lyophilized Acellular Fish Skin in Treating Diabetic Foot Ulcers (DFU) and with Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)
10/12/2022 - 10/12/2025 (PI)
Acera Surgical Inc.

09/14/2021 - 09/14/2024 (PI)
Novo Nordisk

Natural Progression of High-Risk Chronic Limb-Threatening Ischemia. The CLariTI Study.
03/25/2021 - 03/25/2024 (PI)
LimFlow Inc

A comparative evaluation of a marine polysaccharide dressing and a carboxymethylcellulose dressing on subjects with lower extremity venous ulcerss
10/14/2020 - 10/14/2023 (PI)
Medline Industries LLC

Pre notification BEST-CLI Data Analysis and Publications Core
09/01/2022 - 08/31/2023 (PI)
Brigham and Womens Hospital Novo Nordisk Foundat

A multicenter retrospective observational study to evaluate primary patency of arteriovenous fistulae 6 months post-surgery.
11/23/2020 - 04/30/2023 (PI)
Laminate Medical Technologies Inc.

09/17/2013 - 03/31/2023 (PI)
Brigham and Womens Hospital National Heart, Lung

A Pivotal Study to Investigate the Safety and Effectiveness of the Limflow System for the…
12/11/2019 - 12/11/2022 (PI)
LimFlow Inc

A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external suppo
11/01/2017 - 11/01/2022 (PI)
Laminate Medical Technologies Inc.

Showing 10 of 19 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Levin SR, Alonso A, Salazar ED, Farber A, Chitalia VC, King EG, Cheng TW, Siracuse JJ. Recent Evaluation by Nephrologists is Associated with Fewer Tunneled Dialysis Catheter Being Used at the Time of First Arteriovenous Access Creation. J Vasc Surg. 2023 Sep 22.View Related Profiles. PMID: 37742733
  2. Levin SR, Farber A, Goodney PP, King EG, Eslami MH, Malas MB, Patel VI, Kiang SC, Siracuse JJ. Five Year Survival in Medicare Patients Undergoing Interventions for Peripheral Arterial Disease: a Retrospective Cohort Analysis of Linked Registry Claims Data. Eur J Vasc Endovasc Surg. 2023 Oct; 66(4):541-549.View Related Profiles. PMID: 37543356
  3. Dillavou E, Lucas JF, Woodside K, Burgess J, Farber A, Hentschel D, Ozaki CK. VasQ U.S. pivotal study demonstrates the safety and effectiveness of an external vascular support for arteriovenous fistula creation. J Vasc Surg. 2023 Jul 30. PMID: 37527689
  4. Levin SR, Farber A, King EG, Perry AG, Cheng TW, Siracuse JJ. Functional Impairment is Associated with Poor Long-Term Outcomes after Arteriovenous Access Creation. Ann Vasc Surg. 2023 Jul 19.View Related Profiles. PMID: 37479179
  5. Idrees N, Haroon S, Zhang Y, Mangio JC, Siracuse JJ, Francis JM, Ganguli S, Daly K, Diamond M, Vilvendhan R, Cabral H, Dember LM, Farber A, Kolachalama VB, Chitalia VC. Contrast Venography Versus Intravenous Ultrasound in Hemodialysis Arteriovenous Access Dysfunction. Kidney Int Rep. 2023 Sep; 8(9):1887-1891.View Related Profiles. PMID: 37705907; PMCID: PMC10496077; DOI: 10.1016/j.ekir.2023.06.013;
  6. Zhu M, Mota L, Farber A, Schermerhorn ML, King E, Alonso A, Kobzeva-Herzog A, Morrissey N, Malas M, Siracuse JJ. The impact of neighborhood social disadvantage on presentation and management of first-time hemodialysis access surgery patients. J Vasc Surg. 2023 Oct; 78(4):1041-1047.e1.View Related Profiles. PMID: 37331447
  7. Siracuse JJ, Farber A, Menard MT, Conte MS, Kaufman JA, Jaff M, Kiang SC, Ochoa Chaar CI, Osborne N, Singh N, Tan TW, Guzman RJ, Strong MB, Hamza TH, Doros G, Rosenfield K. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial. J Vasc Surg. 2023 Oct; 78(4):1012-1020.e2.View Related Profiles. PMID: 37318428
  8. Cheng TW, Farber A, Levin SR, Arinze N, Garg K, Eslami MH, King EG, Patel VI, Rybin D, Siracuse JJ. Analysis of Early Death after Elective Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2023 Oct; 96:71-80.View Related Profiles. PMID: 37244479; DOI: 10.1016/j.avsg.2023.05.016;
  9. Menard MT, Jaff MR, Farber A, Rosenfield K, Conte MS, White CJ, Beckman JA, Choudhry NK, Clavijo LC, Huber TS, Tuttle KR, Hamza TH, Schanzer A, Laskowski IA, Cziraky MJ, Drooz A, van Over M, Strong MB, Weinberg I. Baseline modern medical management in the BEST-CLI trial. J Vasc Surg. 2023 Sep; 78(3):711-718.e5. PMID: 37201761; PMCID: PMC10528824; DOI: 10.1016/j.jvs.2023.05.006;
  10. Plauche L, Farber A, King EG, Levin SR, Cheng TW, Rybin D, Siracuse JJ. Brachiocephalic and Radiocephalic Arteriovenous Fistulas in Patients with Tunneled Dialysis Catheters Have Similar Outcomes. Ann Vasc Surg. 2023 Oct; 96:98-103.View Related Profiles. PMID: 37178905; DOI: 10.1016/j.avsg.2023.04.032;
Showing 10 of 340 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 337 publications over 25 distinct years, with a maximum of 41 publications in 2016


Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
Contact for Mentoring:

75 E. Newton St Collamore Building
Boston MA 02118
Google Map

Farber's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department